Published in
American Society of Hematology, Blood Advances, 15(2), p. 1807-1816, 2018
DOI: 10.1182/bloodadvances.2018019224
Links
Tools
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories
Journal article published in 2018 by
Sanam Loghavi 
,
Dawen Sui,
Peng Wei,
Guillermo Garcia-Manero ,
Sherry Pierce,
Mark J. Routbort ,
Elias J. Jabbour ,
Naveen Pemmaraju ,
Rashmi Kanagal-Shamanna ,
H. Deniz Gur,
Shimin Hu ,
Zhuang Zuo,
L. Jeffrey Medeiros ,
Hagop M. Kantarjian ,
Joseph D. Khoury
,
Dawen Sui,
Peng Wei,
Guillermo Garcia-Manero ,
Sherry Pierce,
Mark J. Routbort ,
Elias J. Jabbour ,
Naveen Pemmaraju ,
Rashmi Kanagal-Shamanna ,
H. Deniz Gur,
Shimin Hu ,
Zhuang Zuo,
L. Jeffrey Medeiros ,
Hagop M. Kantarjian ,
Joseph D. Khoury
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points Validation of the WHO 2017 CMML categories supports distinguishing MP-CMML from MDS–CMML. The prognostic value of the new 3-tiered blast-based CMML stratification scheme is limited.